Home | Membership Benefits | Seminar | Resources Practice Management | Slideshows & Presentations
					Demo Pages
Management of Menopause Type^®Seminar
Module C: Objective Data
Objective Data
Defining Objective Data | The Goals of Objective Data
In Module A we focused on redefining menopause as a transition that may show up in many different ways and determined that there are actually 12 different Menopause Types^®.
In Module B we focused on subjective data. We recognized the values and the limitations of subjective data and learned how to use the Menopause Type^®. Questionnaire to collect subjective data.
This Module focuses on Objective Data, and the role that it plays in the Management of Menopause Type^®.
Recall that objective data is the second component of the SOAPIER Model, a familiar model composed of seven distinct components. Management of Menopause Types^®. (or any other health condition) is best accomplished through applying this model of case management.
Defining Objective Data
			"Objective: perceptible to persons other than the affected individual "
Signs are objective and can be observed by the five senses. Rashes or other visible skin changes, lumps or masses that can be felt, and heart and lung sounds that can be heard are all objective signs. X-rays, EKG readouts, and laboratory tests also provide objective information that can be used to understand a health condition. Objective lab tests will reveal a true biological hormone deficiency or excess.
Collection of Objective Data
Objective data for menopause management is traditionally collected through physical exams, and diagnostic tests such a lab work, and bone density studies. Unfortunately a menopause work-up still consists of only FSH in many practices.
Since FSH is not a good bio-marker of menopause status ^1 and since menopause may manifest as an imbalance of progesterone and/or testosterone as well as estrogen, traditional blood tests are inadequate. This is easily remedied by measuring all three hormones (estradiol, progesterone and testosterone) as well as SHBG (sex-hormone-binding-globulin). Since SHBG affects the bio-availability of these hormones, assessing it increases the clinical value of serum hormones.
But Menopause Management includes much more than assessing hormone levels. Other biomarkers, including biomarkers of osteoporosis and cardiovascular disease risk assessment, must be a routine component of Menopause Management. These various biomarkers are listed in this module.
Blood tests, salivary hormone tests and urinary tests are discussed in detail in this module.
The Goals of Objective Data
	The primary goal of physical exams, laboratory tests and bone studies is to obtain objective data about the structure and function of tissues and organ systems. Preservation and renewal of structure and function is the ultimate goal.
The specific goals of objective data collection include:
	Assess general health
	Assess bone density
	Assess risk of cardiovascular disease
	Assess cancer risks (breast, colon, lung & genital)
	Assess hormone levels
	Determine Menopause Type^®
With these goals in mind, this module contains the following:
		The Physical Exam
		Techniques and biomarkers used to assess osteoporosis risk.
		The biomarkers used to assess cardiovascular risk.
		Methods and tests used to assess cancer risks.
		Hormone Tests
		Serum hormone tests.
		Salivary hormone tests.
		Urinary hormone tests.
		Menopause Type^® determination with lab tests.
What's Next?
We will briefly review the physical exam that is a routine part of menopause management. We will then provide an overview of osteoporosis tests, cardiovascular tests and cancer risks assessments before turning our attention to assessment of hormones for determining the Menopause Type^®.
				Table of Contents		References
YourMenopauseType.com, Inc. Copyright © & ® | Disclaimer and Legal | Contact Us